myGP to roll out Patient Questionnaires to over 2,400 GP practices
September 28, 2021
A Year to Remember: Reflecting on 2024 at iPLATO
By Tobias Alpsten, CEO and Founder of iPLATO
As 2024 comes to a close, I’ve been reflecting on what has been an extraordinary year for iPLATO. It’s been a year of milestones, growth, and partnerships that have taken us closer to our mission of improving healthcare access and outcomes for millions across the UK. This journey has been filled with proud moments, and I’m excited to share some of them with you.
The most significant step we’ve taken this year was joining forces with eConsult. In October this year, Huma acquired eConsult, a market leader within the digital triage and online consultation space in the UK.Together, we’ve combined iPLATO’s patient communication platform and eConsult’s online triage expertise to create a stronger, more integrated solution for healthcare providers.
What makes this so exciting is the potential we now have to serve over 50 million patients across the UK. We offered every iPLATO GP practice in England access to the iPLATO Toolbar for free, streamlining their patient communications and making it easier to provide timely care. At the same time, eConsult users are benefiting from tools like Selfbook, Connect, Patient Questionnaires and more! iPLATO users can now access eConsult’s structured online consultations.
This merger isn’t just about technology; it’s about the people. By bringing together our expertise, we’re making it easier for practices to offer high-quality care in a way that is accessible, efficient, and cost-effective.
Another highlight of 2024 has been the recognition we’ve received for our work. Winning the Best Virtual Care Project at the HTN Now Awards alongside Huma was a proud moment. The award was for our GDm-Health solution, which helps pregnant women with gestational diabetes manage their condition and enables clinicians to monitor them remotely. It’s a fantastic example of how digital tools can transform healthcare for both patients and providers.
We were also thrilled to be finalists in the British Data Awards, recognised for our efforts in tackling health inequalities. By analysing NHS data and deprivation indices, we’ve helped identify gaps in care and supported better resource allocation. This work is about making sure every patient gets the care they need, regardless of where they live or their circumstances.
We’ve also made great strides in building partnerships that bring tangible benefits to patients and practices. One of the most exciting moments was securing our contract with Wales, where we’ll be providing patient communications for all GP practices. This means practices across the country will have access to tools like the iPLATO Toolbar, enabling them to save time, improve communication, and focus on patient care.
Another important partnership was with Greater Manchester Cancer Alliance to promote the Targeted Lung Health Check programme. By using our Population Health service, we’re encouraging more people to participate in life-saving lung cancer screenings. It’s initiatives like this that remind me why we do what we do—to make a real difference in people’s lives.
We’ve also continued to support regions like Kent and Medway, Lancashire and South Cumbria, and Cambridge and Peterborough with tailored solutions that improve efficiency and free up valuable resources for frontline care.
Three practices in North Central London have reached a remarkable milestone, using our platform for an incredible 20 years! Clerkenwell Medical Practice, City Road Medical Centre, and The Goodinge Group Practice all onboarded in August 2004 and remain valued users of the platform to this day. We extend our gratitude to these practices for their ongoing support and trust in our digital solutions over the years. Here’s to continuing our partnership and driving even more innovation in healthcare together!
Our Population Health service is making strides in public health programmes, our most notable being BEST4 bowel cancer screening. iPLATO plays a pivotal role in partnering with the NHS to drive earlier identification of bowel cancer through innovative digital solutions. Recognising that bowel cancer accounts for 11% of all new cancer cases in the UK, iPLATO focuses on increasing screening uptake among underserved populations, breaking down barriers such as language, stigma, and socio-economic challenges. By delivering targeted SMS reminder programmes and leveraging Digital Patient Questionnaires — achieving completion rates of up to 42% — iPLATO has successfully increased bowel cancer screening uptake by 16%. These efforts help normalise screening within communities, promote education, and support earlier detection at stages 1-2, improving health outcomes while reducing treatment costs.
This year, we celebrated reaching three million users on the myGP app—a milestone that reflects how far we’ve come in empowering people to manage their health. Our app has become a vital tool for booking appointments, managing repeat prescriptions, and even checking blood pressure and skin health from the comfort of home.
In 2024 alone, myGP users booked over 1.1 million appointments and placed more than 12 million repeat prescription orders. We’ve also helped practices reclaim thousands of hours by managing cancellations more efficiently, freeing up time for patients who need it most.
Together with our pharmacy partners – LloydsDirect, Pharmacy2U, PillTime and Phlo – we simplified access to prescription medication through digital first. We also added tools to improve adherence and persistence to prescribed medication.
iPLATO’s partnership with Healthera’s national pharmacy network to enhance the myGP app with advanced Click-and-Collect prescription services and access to bookable pharmacy services, including flu and COVID-19 vaccinations and treatment for common conditions has been hugely successful. Through this partnership, myGP users can now seamlessly book vaccinations and manage prescriptions across over 1,500 local pharmacies in Healthera’s growing network. This integration not only simplifies access to essential healthcare services but also strengthens patient engagement with their local community pharmacies.
With over 30 million people eligible for free flu vaccines and NHS initiatives like Pharmacy First expanding access to care for seven common conditions, iPLATO and Healthera’s collaboration empowers patients to prioritise their health with ease.
Our innovations, like the Autoderm skin checker and Lifelight’s blood pressure checker, are helping people take control of their health in ways that are simple, effective, and accessible. It’s a privilege to see these tools making such a positive impact.
As we head into 2025, I’m more optimistic than ever about what we can achieve. Thank you to everyone who has been part of this journey—our partners, our team, and the millions of patients who trust us to help them manage their health.
Here’s to 2025!
Tobias
© 2026 iPLATO. All rights reserved
myGP to roll out Patient Questionnaires to over 2,400 GP practices
September 28, 2021
A Year to Remember: Reflecting on 2024 at iPLATO
By Tobias Alpsten, CEO and Founder of iPLATO
As 2024 comes to a close, I’ve been reflecting on what has been an extraordinary year for iPLATO. It’s been a year of milestones, growth, and partnerships that have taken us closer to our mission of improving healthcare access and outcomes for millions across the UK. This journey has been filled with proud moments, and I’m excited to share some of them with you.
The most significant step we’ve taken this year was joining forces with eConsult. In October this year, Huma acquired eConsult, a market leader within the digital triage and online consultation space in the UK.Together, we’ve combined iPLATO’s patient communication platform and eConsult’s online triage expertise to create a stronger, more integrated solution for healthcare providers.
What makes this so exciting is the potential we now have to serve over 50 million patients across the UK. We offered every iPLATO GP practice in England access to the iPLATO Toolbar for free, streamlining their patient communications and making it easier to provide timely care. At the same time, eConsult users are benefiting from tools like Selfbook, Connect, Patient Questionnaires and more! iPLATO users can now access eConsult’s structured online consultations.
This merger isn’t just about technology; it’s about the people. By bringing together our expertise, we’re making it easier for practices to offer high-quality care in a way that is accessible, efficient, and cost-effective.
Another highlight of 2024 has been the recognition we’ve received for our work. Winning the Best Virtual Care Project at the HTN Now Awards alongside Huma was a proud moment. The award was for our GDm-Health solution, which helps pregnant women with gestational diabetes manage their condition and enables clinicians to monitor them remotely. It’s a fantastic example of how digital tools can transform healthcare for both patients and providers.
We were also thrilled to be finalists in the British Data Awards, recognised for our efforts in tackling health inequalities. By analysing NHS data and deprivation indices, we’ve helped identify gaps in care and supported better resource allocation. This work is about making sure every patient gets the care they need, regardless of where they live or their circumstances.
We’ve also made great strides in building partnerships that bring tangible benefits to patients and practices. One of the most exciting moments was securing our contract with Wales, where we’ll be providing patient communications for all GP practices. This means practices across the country will have access to tools like the iPLATO Toolbar, enabling them to save time, improve communication, and focus on patient care.
Another important partnership was with Greater Manchester Cancer Alliance to promote the Targeted Lung Health Check programme. By using our Population Health service, we’re encouraging more people to participate in life-saving lung cancer screenings. It’s initiatives like this that remind me why we do what we do—to make a real difference in people’s lives.
We’ve also continued to support regions like Kent and Medway, Lancashire and South Cumbria, and Cambridge and Peterborough with tailored solutions that improve efficiency and free up valuable resources for frontline care.
Three practices in North Central London have reached a remarkable milestone, using our platform for an incredible 20 years! Clerkenwell Medical Practice, City Road Medical Centre, and The Goodinge Group Practice all onboarded in August 2004 and remain valued users of the platform to this day. We extend our gratitude to these practices for their ongoing support and trust in our digital solutions over the years. Here’s to continuing our partnership and driving even more innovation in healthcare together!
Our Population Health service is making strides in public health programmes, our most notable being BEST4 bowel cancer screening. iPLATO plays a pivotal role in partnering with the NHS to drive earlier identification of bowel cancer through innovative digital solutions. Recognising that bowel cancer accounts for 11% of all new cancer cases in the UK, iPLATO focuses on increasing screening uptake among underserved populations, breaking down barriers such as language, stigma, and socio-economic challenges. By delivering targeted SMS reminder programmes and leveraging Digital Patient Questionnaires — achieving completion rates of up to 42% — iPLATO has successfully increased bowel cancer screening uptake by 16%. These efforts help normalise screening within communities, promote education, and support earlier detection at stages 1-2, improving health outcomes while reducing treatment costs.
This year, we celebrated reaching three million users on the myGP app—a milestone that reflects how far we’ve come in empowering people to manage their health. Our app has become a vital tool for booking appointments, managing repeat prescriptions, and even checking blood pressure and skin health from the comfort of home.
In 2024 alone, myGP users booked over 1.1 million appointments and placed more than 12 million repeat prescription orders. We’ve also helped practices reclaim thousands of hours by managing cancellations more efficiently, freeing up time for patients who need it most.
Together with our pharmacy partners – LloydsDirect, Pharmacy2U, PillTime and Phlo – we simplified access to prescription medication through digital first. We also added tools to improve adherence and persistence to prescribed medication.
iPLATO’s partnership with Healthera’s national pharmacy network to enhance the myGP app with advanced Click-and-Collect prescription services and access to bookable pharmacy services, including flu and COVID-19 vaccinations and treatment for common conditions has been hugely successful. Through this partnership, myGP users can now seamlessly book vaccinations and manage prescriptions across over 1,500 local pharmacies in Healthera’s growing network. This integration not only simplifies access to essential healthcare services but also strengthens patient engagement with their local community pharmacies.
With over 30 million people eligible for free flu vaccines and NHS initiatives like Pharmacy First expanding access to care for seven common conditions, iPLATO and Healthera’s collaboration empowers patients to prioritise their health with ease.
Our innovations, like the Autoderm skin checker and Lifelight’s blood pressure checker, are helping people take control of their health in ways that are simple, effective, and accessible. It’s a privilege to see these tools making such a positive impact.
As we head into 2025, I’m more optimistic than ever about what we can achieve. Thank you to everyone who has been part of this journey—our partners, our team, and the millions of patients who trust us to help them manage their health.
Here’s to 2025!
Tobias
© 2026 iPLATO. All rights reserved

myGP to roll out Patient Questionnaires to over 2,400 GP practices
September 28, 2021
Developed to streamline practice workload
Created by iPLATO to offer time-saving support to GP practices burdened by appointment backlogs, Patient Questionnaires is available to both EMIS and SystmOne customers. Once a questionnaire is selected, the patient receives the questionnaire via SMS or via the myGP app. Questionnaires can be scheduled in advance and sent to groups of pre-selected patients. Each SMS sent is saved within the patient’s medical record, making it simple to track when individuals were asked to complete questionnaires. All results are coded to the patient’s medical record.
Tobias Alpsten, CEO at iPLATO, commented ‘We understand current levels of patient demand have left many practices stretched both in terms of time and resource. It’s untenable to expect these practices to operate smoothly, even in the short term, without significant healthtech assistance. We’ve chosen to launch with Blood Pressure and BMI as we know, through conversations with our platform users, there is serious concern that failure to catch recent, lockdown-linked weight gain may create significant future complications for patients. Patient Questionnaires will offer instant insight into potential health risks and ensure patients are placed on treatment programmes sooner rather than later. As we continue to roll out increasingly targeted Patient Questionnaires, we hope to become the first port of call for those looking to review and measure patients remotely.’
A simple solution for preventable conditions
Lockdown has had a significant impact on the population’s health. Research from Public Health England has identified weight gain in over 2 in 5 adults across England, with 1 in 5 gaining a stone or more[1]. This roll out of BMI and blood pressure Patient Questionnaires aims to support primary care in their early detection of key risk indicators, in turn preventing future cases of hypertension, obesity, diabetes and other associated long term conditions. With an estimated 5 million people in England living with undiagnosed high blood pressure[2], it’s vital that GPs can identify at risk patients without relying on individual appointment bookings. According to recent NHS estimates[3], more blood pressure checks have the potential to prevent 3,700 strokes and 2,500 heart attacks over the next 5 years. If used widely by practices across England, Patient Questionnaires will significantly reduce the financial burden on the NHS, both in terms of future savings for preventable conditions and through its market-leading pricing structure. Competitively priced, Patient Questionnaire SMS’ will be costed in the same way as current SMS messaging via the myGP platform, and all questionnaires sent to myGP app users will be free.
Dr. Preeti Shukla, NHS-GP in East Lancashire, added ‘As surgeries across the country face overwhelming demand for services, it’s clear that tools such as Patient Questionnaires will become increasingly central to the early detection of high-risk conditions. Take myGP’s blood pressure questionnaire for example. High blood pressure in a patient can flag potential risk for various cardiovascular issues, such as strokes or heart attacks, and can act as an indicator for dementia. It’s vital that we continue to monitor those with long term conditions, but we must also reach those with currently undiagnosed high blood pressure and start their treatment programmes. The ability to contact large groups simultaneously without the need to manually input individual results is not only time saving for the practice, but also potentially lifesaving for patients.’
Ease of use for patients
Being able to remotely submit results via an SMS saves many patients an unnecessary trip to the GP. BMI is easily measured at home and those who monitor their blood pressure will have a machine at home. For those who don’t, most high street pharmacies offer the service for free.
A weblink is sent to the patient (accessed via smartphone or typed into a browser) and submitting results takes a matter of seconds. To protect against human error, those sent a Patient Questionnaire must verify their identity through a DOB identity check before completing the questionnaire. The link to the pre-set questions will lock if the user enters three incorrect attempts.
Patient Questionnaires Roll Out
Identified as key for many practices, blood pressure and BMI will be the first two Patient Questionnaires available at launch. Once responses have been saved to a patient’s record, they will align to the QOF requirements for the topic in question. Weblinks dedicated to Smoking, Anxiety, Depression, and Ethnicity will feature in the second phase of the Patient Questionnaire roll out. Phase three will see questionnaires for Asthma, COVID Monitoring, Health Checks, COPD, Blood Glucose, O2 Levels, and Peak Flow become available.
iPLATO currently connects 40m patients in the UK with their own NHS GP practice. myGP, which can be accessed via a smartphone app by patients and through a secure web interface by clinicians, is the UK’s largest independent medical app with 2.4 million active users. It is currently used in over 2,400 GP practices.
ENDS
About iPLATO and myGP
Created by health tech company iPLATO Healthcare, myGP is the UK’s largest independent healthcare management app with over 2 million NHS patient users, and 6,500 medical practices right across the country using the app / platform.
The myGP app was created to give NHS patients improved, and more convenient access to healthcare. By making all services available in one app, users can manage and navigate their own healthcare quickly and efficiently, whilst seeing all the options available to them of which they may not have previously been aware.
myGP is the health app of choice for over two million NHS patients. Its most popular patient features include:
iPLATO Healthcare Ltd Company Registered in England & Wales No: 6131747. Registered Office: One King Street, London, W6 9HR iPLATO Healthcare Ltd takes your data privacy seriously. If you would like to find out more, please see our privacy notices (https://www.iplato.com/privacy).
[1] Campaign launched to help public get healthy this summer – GOV.UK (www.gov.uk) Accessed August 2021
[2] Blood Pressure UK Accessed August 2021
[3] NHS England » Nationwide roll-out of NHS high street heart checks to save thousands of lives Accessed August 2021
© 2026 iPLATO. All rights reserved